Toll-Like Receptors Signaling Contributes to Immunopathogenesis of HBV Infection

被引:19
作者
Kondo, Yasuteru [1 ]
Ueno, Yoshiyuki [1 ]
Shimosegawa, Tooru [1 ]
机构
[1] Tohoku Univ Hosp, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
CHRONIC HEPATITIS-B; REGULATORY T-CELLS; LAMIVUDINE THERAPY; IMMUNE-RESPONSES; DENDRITIC CELLS; RIG-I; ACTIVATION; EXPRESSION; REPLICATION; SUPPRESSION;
D O I
10.1155/2011/810939
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Innate and adaptive immune systems have important role in the pathogenesis of acute and chronic infection with hepatitis B virus (HBV). These immune responses are mediated through complex interactions between the innate immune response and adaptive immune response. Toll-like receptors (TLRs) are a family of innate immune-recognition receptors that recognize the molecular patterns associated with microbial pathogens. So far, TLR1 to 13 were found in human or mice and investigated to detect the target molecules and the downstream mechanisms of these unique systems. Stimulation by their ligands initiates the activation of complex networks of intracellular signaling transduction and innate and adaptive immune-related cells (NK, NK-T, monocytes, dendritic cells, T cells, B cells, and Tregs, etc.). However, reports on such relationships between HBV and TLRs have been relatively rare in comparison to those on HCV and TLRs, but have recently been increasing. Thus, a review of TLRs involved in the pathogenesis of HBV infection may be needed toward better understanding of the immunopathogenesis of HBV infection.
引用
收藏
页数:7
相关论文
共 57 条
[1]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[2]   Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].
Angus, P ;
Vaughan, R ;
Xiong, S ;
Yang, HL ;
Delaney, W ;
Gibbs, C ;
Brosgart, C ;
Colledge, D ;
Edwards, R ;
Ayres, A ;
Bartholomeusz, A ;
Locarnini, S .
GASTROENTEROLOGY, 2003, 125 (02) :292-297
[3]   Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection [J].
Baron, JL ;
Gardiner, L ;
Nishimura, S ;
Shinkai, K ;
Locksley, R ;
Ganem, D .
IMMUNITY, 2002, 16 (04) :583-594
[4]   Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B [J].
Boni, C ;
Penna, A ;
Bertoletti, A ;
Lamonaca, V ;
Rapti, I ;
Missale, G ;
Pilli, M ;
Urbani, S ;
Cavalli, A ;
Cerioni, S ;
Panebianco, R ;
Jenkins, J ;
Ferrari, C .
JOURNAL OF HEPATOLOGY, 2003, 39 (04) :595-605
[5]   Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C [J].
Bonorino, Paula ;
Ramzan, Muhammad ;
Camous, Xavier ;
Dufeu-Duchesne, Tania ;
Thelu, Marie-Ange ;
Sturm, Nathalie ;
Dariz, Aurelie ;
Guillermet, Christiane ;
Pernollet, Martine ;
Zarski, Jean-Pierre ;
Marche, Patrice N. ;
Leroy, Vincent ;
Jouvin-Marche, Evelyne .
JOURNAL OF HEPATOLOGY, 2009, 51 (03) :458-467
[6]   Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression [J].
Chang, Wen-Wei ;
Su, Ih-Jen ;
Lai, Ming-Derg ;
Chang, Wen-Tsan ;
Huang, Wenya ;
Lei, Huan-Yao .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (42) :6631-6637
[7]  
CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333
[8]   HEPATITIS-B VIRUS IMMUNOPATHOLOGY [J].
CHISARI, FV ;
FERRARI, C .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1995, 17 (2-3) :261-281
[9]   Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2 [J].
Cooper, A ;
Tal, G ;
Lider, O ;
Shaul, Y .
JOURNAL OF IMMUNOLOGY, 2005, 175 (05) :3165-3176
[10]   Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B [J].
Dahmen, A ;
Herzog-Hauff, S ;
Böcher, WO ;
Galle, PR ;
Löhr, HF .
JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (04) :452-460